CI Investments Inc
ONC icon

CI Investments Inc’s BeOne Medicines Ltd ONC Stock Holding History

CI Investments Inc’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-572
Closed -$123K – 1351
2023
Q1 		$123K Buy
572
+54
+10% +$13K ﹤0.01% 696
2022
Q4 		$114K Buy
518
+387
+295% +$71K ﹤0.01% 713
2022
Q3 		$18K Sell
131
-5
-4% -$859 ﹤0.01% 1055
2022
Q2 		$22K Buy
136
+63
+86% +$9.84K ﹤0.01% 963
2022
Q1 		$14K Hold
73
– – ﹤0.01% 1072
2021
Q4 		$20K Hold
73
– – ﹤0.01% 1076
2021
Q3 		$26K Buy
73
+13
+22% +$4.25K ﹤0.01% 1033
2021
Q2 		$21K Hold
60
– – ﹤0.01% 1011
2021
Q1 		$21K Buy
60
+20
+50% +$6.62K ﹤0.01% 964
2020
Q4 		$10K Buy
40
+20
+100% +$5.51K ﹤0.01% 946
2020
Q3 		$6K Buy
+20
New +$4.7K ﹤0.01% 918

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

CI Investments Inc's ONC Position: Q2 2023 in Review

CI Investments Inc sold out of BeOne Medicines Ltd (ONC) in Q2 2023, closing a stake of 572 shares — an estimated $123K sold.

CI Investments Inc first reported a position in ONC in Q3 2020 and held it in 11 quarters. The position peaked at $123K in Q1 2023. 208 funds tracked by Wall St. Rank hold ONC as of Q2 2023.

  • CI Investments Inc reported no remaining BeOne Medicines Ltd position as of Q2 2023 after selling out during the quarter.
  • CI Investments Inc sold 572 BeOne Medicines Ltd shares in Q2 2023, an estimated $123K.
  • CI Investments Inc first reported a position in BeOne Medicines Ltd in Q3 2020 and held it in 11 quarters.
  • CI Investments Inc's BeOne Medicines Ltd position peaked at $123K in Q1 2023.
  • 208 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2023.

Based on CI Investments Inc's 13F filing for Q2 2023, filed 11 Aug 2023.